BIO FLUORESCENT TECHNOLOGIES INC
8-K, 1996-12-11
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: UNITED STATES CAN COMPANY /DE/, S-4, 1996-12-11
Next: MUNIYIELD NEW YORK INSURED FUND INC, N-30D, 1996-12-11



<PAGE>   1
                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549
                             -----------------------


                                    FORM 8-K


         Current Report Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934

Date of Report (Date of earliest event reported)  November 25, 1996


                       BIO FLUORESCENT TECHNOLOGIES, INC.
             (Exact name of registrant as specified in its charter)



          Nevada                        0-19693                 87-0485320
(State or other jurisdiction    (Commission File Number)       (IRS Employer
     of incorporation)                                       Identification No.)


                           7373 North Scottsdale Road
                                   Suite D222
                            Scottsdale, Arizona 85253
          (Address of principal executive offices, including zip code)


Registrant's telephone number, including area code:  (602) 596-0269

<PAGE>   2



Item 5.  Other Events

                  On November 18, 1996, the Board of Directors of Bio
Fluorescent Technologies, Inc., a Nevada corporation (the "Company"), declared a
one-for-three reverse stock split. The purpose of the reverse stock split is to
increase both the trading price and the overall trading activity of the
Company's shares of Common Stock. The Company's Board of Directors believes that
the reverse stock split is in the best interests of the Company and its
Stockholders.

                   As a result of the reverse stock split, the currently
outstanding 17,812,132 shares of the Company's $0.001 par value Common Stock
shall be reconstituted and converted into 5,937,378 shares of $0.001 par value
Common Stock.

                  In addition to the foregoing, the Company will be authorized
to issue Eight Million Three Hundred Thirty Three Thousand, Three Hundred Thirty
Four (8,333,334) shares of Common Stock, instead of the Twenty Five Million
(25,000,000) shares of Common Stock currently authorized.

                  In connection with the reverse stock split, the Company shall
reconstitute and convert all currently outstanding warrants and options to
purchase an aggregate of 1,990,000 shares of Common Stock, constituting the only
outstanding class of equity shares into an aggregate of one-third such amount or
663,334 shares.

                  No vote of the Company's Stockholders is required for the
reverse stock split, which shall be effective as of December 2, 1996.

                  For further information, see the Officers' Certificate and the
Written Consent in Lieu of Special Meeting of the Board of Directors filed
herewith as Exhibits 1.1 and 1.2.


                                        2

<PAGE>   3




Item 7.  Financial Statements and Exhibits

                  (c)      Exhibits.

1.1                        Officers' Certificate, pursuant to Section 78.207 of
                           the General Corporation Law of Nevada, dated November
                           18, 1996.

1.2                        Written Consent in Lieu of Special Meeting of the
                           Board of Directors, pursuant to Section 78.315 of the
                           General Corporation Law of Nevada, dated November 18,
                           1996.


                                        3

<PAGE>   4





                                   SIGNATURES

                  Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

Dated:  November 29, 1996     BIO FLUORESCENT TECHNOLOGIES, INC.



                               By: /s/Jan Olivier
                                   ---------------------------------------------
                                      Jan Olivier, President and Chief Executive
                                      Officer


                                        4

<PAGE>   5


                                  EXHIBIT INDEX


Exhibit                                                    Sequentially Numbered
Number            Description                              Page


1.1               Officers' Certificate, pursuant to Section
                  78.207 of the General Corporation Law of
                  Nevada, dated November 18, 1996.

1.2               Written Consent in Lieu of Special Meeting
                  of the Board of Directors, pursuant to
                  Section 78.315 of the General Corporation
                  Law of Nevada, dated November 18, 1996.


<PAGE>   1
                                                                Exhibit 1.1
         FILED
  IN THE OFFICE OF THE
SECRETARY OF STATE OF THE
     STATE OF NEVADA         OFFICERS' CERTIFICATE
                             PURSUANT TO NRS 78-207
       DEC 02 1996
        C-1236-90

DEAN HELLER SECRETARY OF STATE

      /s/ DEAN HELLER



        The undersigned certify that:

        1.  They are the president and the secretary, respectively, of Bio
            Fluorescent Technologies, Inc., a Nevada corporation (the
            "Company").

        2.  The Company has declared a one for three reverse stock split.

        3.  Prior to the one for three reverse stock split, the Company had
            authorized Twenty Five Million (25,000,000) shares of common stock,
            par value $0.0001 per share.

        4.  After the one for three reverse stock split, the Company will have
            authorized Eight Million, Three Hundred Thirty Three Thousand, Three
            Hundred Thirty Four (8,333,334) shares of common stock, par value
            $0.001 per share.

        5.  The Company shall reconstitute and convert all currently outstanding
            warrants and options to purchase an aggregate of One Million Nine
            Hundred Ninety Thousand (1,990,000) shares of Common Stock,
            constituting the only outstanding class of equity shares into an
            aggregate of one-third such amount or Six Hundred Sixty Three
            Thousand Three Hundred Thirty Four (663,334) shares. Any fractional
            shares resulting from the reverse stock split will be rounded up
            into the nearest whole share.

        5.  No vote of the shareholders is required for the reverse stock split.

        6.  The reverse stock split shall be effective as of December 2, 1996.

        We further declare under penalty of perjury under the laws of the State
of Nevada that the matters set forth in this Certificate are true and correct of
our own knowledge.


Date: November 18, 1996

                                                     /s/ JAN J. OLIVIER        
                                                -----------------------------
                                                           President


                                                  /s/ A. RICHARD BULLOCK    
                                                -----------------------------
                                                           Secretary


<PAGE>   1
                                                               EXHIBIT 1.2


                                WRITTEN CONSENT
                                       OF
                                   DIRECTORS
                                       OF

                       BIO FLUORESCENT TECHNOLOGIES, INC.
                             (A Nevada corporation)



                The undersigned, constituting all of the directors of Bio
Fluorescent, Inc., a Nevada corporation (the "Corporation"), hereby adopt the
following resolutions by written consent pursuant to Section 78.315 of the
Nevada General Corporation Law:

                WHEREAS, the Board of Directors has been presented with a
                proposal to authorize a one-for-three reverse stock split in
                accordance with the form of Officers' Certificate attached
                hereto as Exhibit A ("the Reverse Stock Split");

                WHEREAS, a vote of the shareholders is not required to effect a
                reverse stock split pursuant to Section 78.207 of the Nevada
                General Corporation Law;

                NOW, THEREFORE, BE IT RESOLVED, that the Reverse Stock Split be
                and hereby is approved.

                RESOLVED FURTHER, that any one or more of the Officers of the
                Corporation (the "Authorized Party") hereby is authorized,
                empowered and directed, in the name and on behalf of the
                Corporation, to execute and deliver the Reverse Stock Split
                substantially in the form presented to and considered by this
                Board of Directors, with such modifications therein as the
                Authorized Party executing the same on its behalf shall in his
                sole discretion determine, such determination to be conclusively
                evidenced by his execution and delivery thereof;

                RESOLVED, that the President, or any other executive officer of
                the Corporation, be, and each of them hereby is, authorized, in
                the name and on behalf of the Corporation, to make all such
                arrangements, to do and perform all such acts and things, and to
                execute and deliver all such officers' certificates and such
                other instruments and documents as they may deem necessary or
                appropriate in order to effectuate the Reverse Stock Split or
                any of the foregoing resolutions (hereby ratifying and
                confirming any and all actions taken heretofore and hereafter to
                accomplish such purposes, all or singular); and 
<PAGE>   2
RESOLVED FURTHER, that the authority and power given hereunder shall be deemed
retroactive and any and all acts authorized hereunder performed prior to the
passage of this resolution are hereby approved, confirmed and ratified.

IN WITNESS WHEREOF, the undersigned have hereunto set their hands as of the
18th day of November, 1996.


                                        /s/ RAY A. TRIPHAHN
                                        ----------------------------------
                                        Ray A. Triphahn


                                        /s/ A. RICHARD BULLOCK
                                        ----------------------------------
                                         A. Richard Bullock


                                        /s/ JAN J. OLIVIER
                                        ----------------------------------
                                         Jan J. Olivier




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission